FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588300170> ?p ?o ?g. }

• W2588300170 endingPage "1970" @default.
• W2588300170 startingPage "1965" @default.
• W2588300170 abstract "BACKGROUND Patients with primary refractory acute lymphoblastic leukemia (PREF ALL) who fail to achieve a complete remission (CR) after ≥2 courses of chemotherapy have a dismal prognosis without undergoing allogeneic hematopoietic cell transplantation (HCT). To the authors' knowledge, there currently are no data regarding factors influencing transplantation outcomes. METHODS The authors retrospectively studied outcomes of transplantation for cases of PREF ALL reported to European Society for Blood and Marrow Transplantation registry. Eligibility criteria for the current analysis included adult patients who underwent their first HCT for PREF ALL between 2000 and 2012. PREF disease was defined as the failure to achieve a morphological CR after ≥2 courses of induction chemotherapy. RESULTS Data regarding 86 adult patients were analyzed. With a median follow‐up of 106 months, the probability of survival was 36% at 2 years and 23% at 5 years. The probability of leukemia‐free survival was 28% and 17%, respectively, and the probability of nonrecurrence mortality was 20% and 29%, respectively, at 2 years and 5 years. For 66 patients who achieved a CR (77%), the survival at 2 years and 5 years was 36% and 29%, respectively. In multivariate analysis, use of total body irradiation was found to be associated with improved survival. Total body irradiation and infusion of female hematopoietic cells into male recipients was associated with improved leukemia‐free survival. These findings were incorporated into a scoring system that identified 3 groups (those with 2, 1, or no prognostic factors) with survival rates of 57%, 22%, and 8%, respectively. CONCLUSIONS Although overall these patients would clearly benefit from the introduction of novel antileukemic therapies, the data from the current study support the use of allogeneic HCT in selected patients with PREF ALL. Cancer 2017;123:1965–1970 . © 2017 American Cancer Society ." @default.
• W2588300170 created "2017-02-24" @default.
• W2588300170 creator A5006288618 @default.
• W2588300170 creator A5012033727 @default.
• W2588300170 creator A5018345688 @default.
• W2588300170 creator A5020996390 @default.
• W2588300170 creator A5025217094 @default.
• W2588300170 creator A5030235127 @default.
• W2588300170 creator A5035666187 @default.
• W2588300170 creator A5040417184 @default.
• W2588300170 creator A5042552205 @default.
• W2588300170 creator A5044096443 @default.
• W2588300170 creator A5047186106 @default.
• W2588300170 creator A5051463822 @default.
• W2588300170 creator A5058925624 @default.
• W2588300170 creator A5069313785 @default.
• W2588300170 date "2017-02-17" @default.
• W2588300170 modified "2023-10-16" @default.
• W2588300170 title "Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT" @default.
• W2588300170 cites W1860800305 @default.
• W2588300170 cites W1861829463 @default.
• W2588300170 cites W1993665924 @default.
• W2588300170 cites W1994351520 @default.
• W2588300170 cites W2005302631 @default.
• W2588300170 cites W2017386473 @default.
• W2588300170 cites W2035800776 @default.
• W2588300170 cites W2077173355 @default.
• W2588300170 cites W2079801336 @default.
• W2588300170 cites W2082261439 @default.
• W2588300170 cites W2084267226 @default.
• W2588300170 cites W2143034151 @default.
• W2588300170 cites W2195410532 @default.
• W2588300170 cites W2332175111 @default.
• W2588300170 cites W2424740985 @default.
• W2588300170 cites W2469879612 @default.
• W2588300170 cites W70277491 @default.
• W2588300170 doi "https://doi.org/10.1002/cncr.30604" @default.
• W2588300170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28211939" @default.
• W2588300170 hasPublicationYear "2017" @default.
• W2588300170 type Work @default.
• W2588300170 sameAs 2588300170 @default.
• W2588300170 citedByCount "27" @default.
• W2588300170 countsByYear W25883001702017 @default.
• W2588300170 countsByYear W25883001702018 @default.
• W2588300170 countsByYear W25883001702019 @default.
• W2588300170 countsByYear W25883001702020 @default.
• W2588300170 countsByYear W25883001702022 @default.
• W2588300170 crossrefType "journal-article" @default.
• W2588300170 hasAuthorship W2588300170A5006288618 @default.
• W2588300170 hasAuthorship W2588300170A5012033727 @default.
• W2588300170 hasAuthorship W2588300170A5018345688 @default.
• W2588300170 hasAuthorship W2588300170A5020996390 @default.
• W2588300170 hasAuthorship W2588300170A5025217094 @default.
• W2588300170 hasAuthorship W2588300170A5030235127 @default.
• W2588300170 hasAuthorship W2588300170A5035666187 @default.
• W2588300170 hasAuthorship W2588300170A5040417184 @default.
• W2588300170 hasAuthorship W2588300170A5042552205 @default.
• W2588300170 hasAuthorship W2588300170A5044096443 @default.
• W2588300170 hasAuthorship W2588300170A5047186106 @default.
• W2588300170 hasAuthorship W2588300170A5051463822 @default.
• W2588300170 hasAuthorship W2588300170A5058925624 @default.
• W2588300170 hasAuthorship W2588300170A5069313785 @default.
• W2588300170 hasBestOaLocation W25883001701 @default.
• W2588300170 hasConcept C121332964 @default.
• W2588300170 hasConcept C126322002 @default.
• W2588300170 hasConcept C141071460 @default.
• W2588300170 hasConcept C142424586 @default.
• W2588300170 hasConcept C143998085 @default.
• W2588300170 hasConcept C2776694085 @default.
• W2588300170 hasConcept C2776755627 @default.
• W2588300170 hasConcept C2776863199 @default.
• W2588300170 hasConcept C2777408962 @default.
• W2588300170 hasConcept C2778461978 @default.
• W2588300170 hasConcept C2778880498 @default.
• W2588300170 hasConcept C2781107101 @default.
• W2588300170 hasConcept C2909962599 @default.
• W2588300170 hasConcept C2911091166 @default.
• W2588300170 hasConcept C38180746 @default.
• W2588300170 hasConcept C71924100 @default.
• W2588300170 hasConcept C87355193 @default.
• W2588300170 hasConceptScore W2588300170C121332964 @default.
• W2588300170 hasConceptScore W2588300170C126322002 @default.
• W2588300170 hasConceptScore W2588300170C141071460 @default.
• W2588300170 hasConceptScore W2588300170C142424586 @default.
• W2588300170 hasConceptScore W2588300170C143998085 @default.
• W2588300170 hasConceptScore W2588300170C2776694085 @default.
• W2588300170 hasConceptScore W2588300170C2776755627 @default.
• W2588300170 hasConceptScore W2588300170C2776863199 @default.
• W2588300170 hasConceptScore W2588300170C2777408962 @default.
• W2588300170 hasConceptScore W2588300170C2778461978 @default.
• W2588300170 hasConceptScore W2588300170C2778880498 @default.
• W2588300170 hasConceptScore W2588300170C2781107101 @default.
• W2588300170 hasConceptScore W2588300170C2909962599 @default.
• W2588300170 hasConceptScore W2588300170C2911091166 @default.
• W2588300170 hasConceptScore W2588300170C38180746 @default.
• W2588300170 hasConceptScore W2588300170C71924100 @default.
• W2588300170 hasConceptScore W2588300170C87355193 @default.
• W2588300170 hasFunder F4320319990 @default.

• next